ANGPT2 exhibited significantly elevated preoperative levels in patients with RCC (p = 0.046) compared to those with benign disease, while preoperative TuM2PK and VEGF levels were comparable between patients with benign and malignant disease (Figure 1). Here, ANGPT2 is linked to renal cell carcinoma.